EUDA Health Stock Forward View - Triple Exponential Smoothing
| EUDA Stock | 0.49 -0.01 -2.00% |
Predicting EUDA Health's future price is a multi-variable problem that combines fundamental signals, technical structure, and market sentiment. This module focuses specifically on the hype and news dimension of that forecast.
At present, the short-cycle RSI for EUDA Health stands at 34, indicating moderately negative momentum. For EUDA Health, this sub-50 reading points to a soft downward drift rather than an aggressive selloff.Momentum
Sell Stretched
Oversold | Overbought |
This section relates EUDA Health Holdings headline activity to recent price behavior and peer context.
The Triple Exponential Smoothing forecasted value of EUDA Health Holdings on the next trading day is expected to be 0.42 with a mean absolute deviation of 0.13 and the sum of the absolute errors of 7.66.EUDA Health after-hype prediction price | $ 0.49 |
Hype signals are presented as complementary context to forecasting, technicals, analyst estimates, earnings, and momentum.
Use Historical Fundamental Analysis of EUDA Health to cross-verify projections for EUDA Health. The historical view provides additional context.EUDA Health Additional Predictive Modules
Most predictive techniques to examine EUDA price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for EUDA using various technical indicators. When you analyze EUDA charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Triple Exponential Smoothing Price Forecast For the 14th of March 2026
Given 90 days horizon, the Triple Exponential Smoothing forecasted value of EUDA Health Holdings on the next trading day is expected to be 0.42 with a mean absolute deviation of 0.13 , mean absolute percentage error of 0.07 , and the sum of the absolute errors of 7.66 .Please note that although there have been many attempts to predict EUDA Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that EUDA Health's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest EUDA Health | EUDA Health Price Prediction | Research Analysis |
Forecasted Value
This next-day forecast for EUDA Health Holdings uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of EUDA Health stock data series using in forecasting. Note that when a statistical model is used to represent EUDA Health stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | 0.0375 |
| MAD | Mean absolute deviation | 0.1298 |
| MAPE | Mean absolute percentage error | 0.102 |
| SAE | Sum of the absolute errors | 7.6604 |
The concept of mean reversion suggests that EUDA Health's price will eventually return toward its long-run average. High prices may deter value investors, while unusually low prices often attract buyers who anticipate a recovery.
After-Hype Price Density Analysis
The price distribution graph for EUDA Health visualizes the statistical uncertainty around our prediction model's output. Investors should interpret the full distribution of EUDA Health's outcomes, not just the central tendency, when making decisions.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
The downside and upside margins for EUDA Health after major news events are estimated from historical precedent. EUDA Health's after-hype downside and upside margins for the prediction period are 0.02 and 13.51, respectively. This approach captures the empirical distribution of EUDA Health's short-term price reactions without assuming any particular model of future behavior.
Current Value
The after-hype framework applied to EUDA Health Holdings assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as EUDA Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading EUDA Health backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with EUDA Health, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.52 | 13.02 | 0.00 | 0.03 | 0 Events | 3 Events | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.49 | 0.49 | 0.00 |
|
Hype Timeline
EUDA Health Holdings is currently traded for 0.49. The company stock is not elastic to its hype. The average elasticity to hype of competition is -0.03. EUDA is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at -1.52%. %. The volatility of related hype on EUDA Health is about 76588.24%, with the expected price after the next announcement by competition of 0.46. About 37.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in a few days. Use Historical Fundamental Analysis of EUDA Health to cross-verify projections for EUDA Health. The historical view provides additional context.Related Hype Analysis
The relationship between EUDA Health and its sector peers means that news affecting one company often reverberates across EUDA Health's competitive landscape. Tracking peer hype helps investors anticipate EUDA Health's likely short-term price behavior.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AMWL | American Well Corp | 0.00 | 0 per month | 2.82 | 0.09 | 6.85 | -4.85 | 31.73 | |
| HYPR | Hyperfine | 0.01 | 6 per month | 3.23 | 0.06 | 8.42 | -6.19 | 18.91 | |
| ZTEK | ZEN Graphene Solutions | 0.00 | 0 per month | 3.80 | 0.01 | 7.25 | -6.76 | 34.15 | |
| QNCX | Quince Therapeutics | 0.00 | 0 per month | 19.57 | 0.01 | 11.07 | -24.00 | 369.99 | |
| FONR | Fonar | 0.00 | 0 per month | 0.00 | 0.13 | 1.45 | -0.69 | 27.57 | |
| DTIL | Precision BioSciences | 0.08 | 9 per month | 3.52 | 0.07 | 8.24 | -5.57 | 19.01 | |
| GUTS | Fractyl Health Common | -0.28 | 8 per month | 0.00 | -0.15 | 6.60 | -8.44 | 79.65 | |
| ATYR | aTyr Pharma | 0.02 | 5 per month | 3.73 | 0.05 | 10.11 | -7.22 | 35.75 | |
| ADVM | Adverum Biotechnologies | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FORA | Forian Inc | 0.00 | 0 per month | 0.00 | -0.002 | 0.97 | -1.43 | 6.49 |
Other Forecasting Options for EUDA Health
Whether a novice or experienced investor, anyone considering EUDA needs to understand the dynamics of EUDA Health's price movement. Price charts for EUDA Stock contain a significant amount of noise that can distort investment decisions.EUDA Health Related Equities
The following equities are related to EUDA Health within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing EUDA Health against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
EUDA Health Market Strength Events
Analyzing market strength indicators for EUDA Health enables investors to understand how the stock performs relative to overall market momentum. These indicators are valuable tools for identifying when to enter or exit positions in EUDA Health Holdings.
| Accumulation Distribution | 11173.68 | |||
| Daily Balance Of Power | -0.20 | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 0.51 | |||
| Day Typical Price | 0.5 | |||
| Price Action Indicator | -0.02 | |||
| Period Momentum Indicator | -0.01 |
EUDA Health Risk Indicators
Identifying and analyzing EUDA Health's key risk indicators is a foundational step in projecting how its price may evolve. This process helps investors quantify the risk associated with EUDA Health's and decide how to manage it.
| Mean Deviation | 7.52 | |||
| Standard Deviation | 13.02 | |||
| Variance | 169.51 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for EUDA Health
Coverage intensity for EUDA Health Holdings matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
EUDA Health Short Properties
Short sentiment tied to EUDA Health Holdings matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 32.5 M | |
| Cash And Short Term Investments | 237.6 K |
More Resources for EUDA Stock Analysis
A structured review of EUDA Health Holdings often starts with core financial statements and trend context. Financial ratios provide context for profitability, efficiency, and growth trends. Below are reports that help frame EUDA Health Holdings Stock in context:Use Historical Fundamental Analysis of EUDA Health to cross-verify projections for EUDA Health. The historical view provides additional context. Analysis related to EUDA Health should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
The market value of EUDA Health Holdings is measured differently than book value, which reflects EUDA accounting equity. EUDA Health's market capitalization is 18.95 M. Enterprise value stands at 21.09 M. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
Note that EUDA Health's intrinsic value and market price are different measures derived from different inputs. For EUDA Health, key inputs include a profit margin of 5.17%, and revenue of 4.01 M. Trading price represents the transaction level agreed by market participants.